Objective: To determine which glucose levels are associated with improved morbidity and mortality in thermally injured patients. Summary background data: Tight euglycemic control was rapidly implemented in intensive care units around the world, but there is increasing evidence that tight euglycemic control is associated with detrimental outcomes. Currently, no study exists that indicates which glucose range should be targeted. Methods: Two-hundred and eight severely burned pediatric patients with burns over 30% of their total body surface area were included in this trial. Several statistical models were used to determine the daily average and 6 AM glucose target that were associated with improved morbidity and mortality. Patients were then divided into good glucose controlled and poor glucose controlled patients and demographics, clinical outcomes, infection, sepsis, inflammatory, and hypermetabolic responses were determined. Results: Statistical modeling showed that hyperglycemia is a strong predictor of adverse hospital outcome and that daily 6 AM glucose level of 130 mg/dL and daily average glucose levels of 140 mg/dL are associated with improved morbidity and mortality postburn. When patients were divided into good glucose control and poor glucose control, we found that patients with glucose levels of 130 mg/dL exert attenuated hypermetabolic and inflammatory responses, as well as significantly lower incidence of infections, sepsis, and mortality compared with patients with poor glucose control, P Ͻ 0.05. Conclusions: Given the controversy over glucose range, glucose target, and risks and detrimental outcomes associated with hypoglycemia we suggest that in severely burned patient's blood glucose of 130 mg/dL should be targeted. (Ann Surg 2010;252: 521-528) 
H yperglycemia is a common pathophysiological phenomenon in burn and critically ill patients. During the early phases of postburn, hyperglycemia is due to an increased rate of glucose appearance along with an impaired tissue extraction of glucose leading to an increase of glucose and lactate 1,2 associated with impaired insulin receptor signaling and endoplasmic reticulum stress. [3] [4] [5] The clinical relevance of hyperglycemia after a severe burn was shown in recent studies in which the authors showed that burn patients with poor glucose control had a significantly higher incidence of bacteremia/fungemia and mortality. 6 -8 These data indicate that hyperglycemia, associated with insulin resistance, represents a significant clinical problem in burn patients similar to insulin resistance in critically ill patients. Tight euglycemic control as published by van den Berghe et al 9 changed the intensive care unit (ICU) practice. They showed that insulin administered to maintain glucose at levels below 110 mg/dL decreased morbidity and mortality in surgically critically ill patients and morbidity in medically critically ill patients. 10 In another study, the authors showed that tight euglycemic control improved mortality in pediatric ICU patients 11 and insulin given during the acute phase not only improved acute hospital outcomes but also improved long-term rehabilitation and social reintegration of critically ill patients over a period of 1 year, 12, 13 indicating the advantage of insulin therapy.
Various unicenter and multicenter studies followed the Leuven trials to determine whether tight euglycemic control, in fact, improves outcomes of critically ill, septic, trauma, and medical patients. Results of these studies were mixed with some showing a benefit with the use of euglycemic control, 14, 15 whereas others failed to show improved outcomes; in contrast, some of these studies even demonstrated detrimental effects associated with tight euglycemic control and a dramatically increase in the incidence of hypoglycemia. 16 A large multicenter trial was initiated: the NICE SUGAR trial, which failed to show beneficial outcome for critically ill patients with intensive insulin therapy. 17 This trial on the other hand delineated risks and problems associated with tight euglycemic therapy. Given all these controversial findings, current recommendations which glucose range should be targeted, are now based on opinions and not on scientific evidence.
We, therefore, designed this trial in severely burned patients to answer the question which glucose levels are associated with improved morbidity and mortality. We hypothesized that hypoglycemia as well as hyperglycemia are detrimental for severely thermally injured patient outcome and that an ideal glucose range exists that is associated with improved morbidity and mortality.
PATIENTS AND METHODS
Thermally injured children with burns over 30% of their total body surface area (TBSA) who consented to an IRB-approved experimental protocol between 2002 and 2009 and who were randomized to control (patients did not receive any anabolic or anticatabolic experimental drug) or randomized to tight euglycemic or conventional insulin, requiring at least one surgical intervention were included in this study.
Glucose levels were checked as needed by using a laboratory hexokinase assay. A total of 208 patients were included into this trial. For these 208 patients, daily average and 6 AM glucose levels were collected and a statistical analysis performed (see below) that divided these patients into good glucose control versus poor glucose control and subsequent parameters were determined. Daily average glucose measurements are all glucose measurements obtained in one day in the same patient. The amount of glucose measurements varied for each patient from 6 measurements per day to 24 measurements per day depending on the acuity of the burn injury and the patient's critical condition. Daily 6 AM glucose levels were glucose levels that were determined every day at 6 AM during the hospitalization of the patient resulting in one daily value.
If needed, patients were resuscitated according to the Galveston formula with 5000 mL/m 2 TBSA burned ϩ 2000 mL/m 2 TBSA lactated Ringer's solution given in increments over the first 24 hours. Within 48 hours of admission, all patients underwent total burn wound excision and the wounds were covered with autograft. Any remaining open areas were covered with homograft. After the first operative procedure, patients were taken back to the operation theater when donor sites were healed. This procedure was repeated until all open wound areas were covered with autologous skin. All patients underwent the same nutritional treatment according to a standardized protocol. The intake was calculated as 1500 kcal/m 2 body surface ϩ 1500 kcal/m 2 area burn as previously published. 18 -20 The nutritional route of choice in our patient population was enteral nutrition via a duodenal (Dobhof) or nasogastric tube. Patient demographics (age, date of burn and admission, sex, burn size, and depth of burn) and concomitant injuries such as inhalation injury, sepsis, morbidity, and mortality were recorded. Inhalation injury was diagnosed by bronchoscopy along with a consistent history. Wound infection was defined as Ͼ10 5 colony forming units per gram tissue in a wound biopsy with the identification of a pathogen. Repeated counts of the same bacteria in the same location were counted as the same infection. Sepsis and infection were defined by the American Burn Association and Society of Critical Care Medicine guidelines. 18, 21, 22 Multiorgan failure (MOF) was defined as previously published.
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Ethics
The study was reviewed and approved by the Institutional Review Board of the University Texas Medical Branch, Galveston, Texas. Prior to the study, each subject, parent or child's legal guardian had to sign a written informed consent form.
Statistics
We used several statistical methods (backward stepwise regression, factor analysis, and principal component analysis) to determine which independent variables contribute to predicting mortality, and compared their results to best fit the mortality model. Robust estimation techniques were used to estimate the covariance matrix of the data. Based on the output of the backward stepwise regression and principal component analysis, there were independent variables that appeared to be highly correlated with other independent variables or had no variability and therefore these variables were removed from the regression model. We used 2 glucose markers: daily average glucose and glucose level at 6:00 AM for each patient to determine association between patient outcome and glucose levels.
In both cases (daily average and 6:00 AM), TBSA%, %good140 and %good130, were significant parameters, respectively, in developing the prediction model for mortality, other variables did not significantly add to the ability of the equation to predict the mortality and were not included in the final equation because of the multicollinearity, or collinearity, relationships among the independent variables. We modeled mortality using the multivariate logistic regression. In our multiple logistic regression, we used hierarchical forward with switching model with max 50 iterations.
To calculate a probability from the logistic equation, the logit was transformed using Probability ͓survive͔ ϭ 1/͓1 ϩ Exp {ϪLogit P}͔. To assess the regression fit for the analysis, the likelihood ratio test statistic and the mean, standard error, and Wald statistic for each parameter were examined. The sensitivity and specificity of the resulting logistic regression was depending on the Logit P value, which is considered to be predictive of mortality. The relationship between sensitivity and specificity was presented as a receiver operating characteristic curve. These analyses were performed using several statistical analysis system packages (SigmaStat, and NCSS). Analysis of variance with post hoc Bonferroni correction, paired and unpaired Student t test, 2 analysis, and Mann-Whitney tests were used where appropriate. Data are expressed as means Ϯ SD or SEM, where appropriate. Significance was accepted at P Ͻ 0.05.
Hypermetabolism and Insulin Resistance
Glucose Metabolism and Insulin Resistance
During acute hospitalization, we determined daily average blood glucose levels, daily 6 AM blood glucose levels, daily maximum glucose levels, and daily minimum glucose levels. Glucose concentration was determined in our clinical laboratory by hexokinase assay (Siemens Healthcare Diagnostics, West Sacramento, CA). We further determined the number of patients requiring insulin administration during acute hospitalization and the daily amount of insulin needed per patient, as well as serum insulin levels during acute hospitalization.
Indirect Calorimetry
All patients underwent resting energy expenditure (REE) measurements within 1 week following hospital admission and weekly thereafter during their acute hospitalization. All measurements of REE were performed between midnight and 5 AM while the patients were asleep and receiving continuous feeding. Resting energy expenditure was measured using a Sensor-Medics Vmax 29 metabolic cart (Yorba Linda, CA) as previously published. 20 REE was calculated from oxygen consumption and carbon dioxide production using equations described by Mlcak et al. 20 Measured values were compared with predicted normal values, based on the HarrisBenedict equation, and to body mass index. 20 
Cytokines, Hormones, and Proteins
Blood and urine were collected from each burn patient at admission, preoperatively, and 5 days postoperatively for 4 weeks and were used for analysis of serum hormone, protein, cytokine, and urine hormones. Blood was drawn in a serum-separator collection tube and centrifuged for 10 minutes at 1320 rpm; the serum was removed and stored at Ϫ70°C until assayed. Serum hormones and acute phase proteins were determined using HPLC, nephelometry (BNII, Plasma Protein Analyzer Siemens Healthcare Diagnostics, West Sacramento, CA), and ELISA techniques. 23 The Bio-Plex Human Cytokine 17-Plex panel was used with the Bio-Plex Suspension Array System (Bio-Rad, Hercules, CA) to profile expression of seventeen inflammatory mediators. 24 
Organ Function
Serum proteins, eg, creatinine, bilirubin, and total protein were determined using standard nephelometry to evaluate organ function.
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RESULTS
Demographics
Two-hundred and eight patients were included in this study. Demographics are shown in Table 1 . Daily average and daily 6:00 AM glucose levels were measured and statistical analysis were performed to determine what glucose level is associated with an improved outcome. We applied backward stepwise regression, factor analysis, and principal component analysis to determine which parameters significantly affect mortality. Based on the results from applying principal component analysis, for the daily glucose average levels, we found a daily glucose average level of 140 mg/dL to be the best glucose level with the highest weight assigned on it. We further determined how often a patient has to be in the range of 140 mg/dL to have an improved outcome. We obtained that a patient needs to be at least 70% of the entire hospitalization in that range. For the 6:00 AM glucose level, we found that a glucose level of 130 mg/dL to be the ideal, and a patient needs to be at least 75% of the time in that range.
Multiple logistic regressions were conducted using the most informative and significant variables, TBSA and %good140; TBSA and %good130, respectively (for the 2 data sets daily average and 6:00 AM), to develop the mortality model and the following equations were obtained:
The coefficients for %good140 and %good130 were negative, indicating that the risk of mortality decreased with the increase of these variables. The coefficients for TBSA were positive, and it indicates that patients with a bigger burn are more likely to die compared with patients with smaller TBSA. The means, SEs, and Wald statistics of the logistic regression coefficients for the daily glucose average and 6:00 AM, respectively, are as follows: %good140, 0.67 Ϯ 1.72824, P Յ 0.001 and TBSA, 56 Ϯ 0.02862, P Յ 0.001; % good130, 0.58 Ϯ 2.24, P Յ 0.001, and TBSA, 58 Ϯ 0.027, P Յ 0.001.
From multiple regression analysis, we identified burn size, daily average, and 6:00 AM glucose levels as excellent predictors for mortality (Likelihood Ratio Test Statistic 66.074; P ϭ Ͻ0.001, Likelihood Ratio Test Statistic 50.877; P ϭ Ͻ0.001). An receiver operating characteristic curve was constructed for the resulting regression equation and the area under the curve for daily average glucose was 0.96 and for 6:00 AM was 0.92 (Figs. 1A, B, Supplemental Digital Content 2, online only, available at: http://links.lww.com/SLA/A85). The percent correct classification rate were high for the daily average glucose level using glucose level of 140 mg/dL (94.7% total correct classification rate), and for the 6:00 AM measurements, glucose level of 130 mg/dL (95.7% total correct classification rate). Results show that burn patients whose glucose levels are at 140 mg/dL for 70% of their acute hospitalization have an improved outcome compared with patients with glucose levels higher than 140 mg/dL, as well as patients whose 6:00 AM glucose are at 130 mg/dL for 75% of the time (Figs. 1C-J, Supplemental Digital Content 2, online only, available at: http://links.lww.com/SLA/A85).
Using the 6:00 AM cutoff, 130 mg/dL for at least 75% of the entire hospitalization, we divided patients into poor glucose controlled patients and good glucose controlled patients. At hospital admission, there were no differences in patient demographics as shown in Table 1 , except good glucose controlled patients were younger than poorly controlled patients. There were no statistical differences in gender, length of ICU stay, burn size, third-degree burn, length of ICU stay per percent burn, or number of required operations ( Table 1) . Incidence of inhalation injury was comparable in both groups and not statistically different (Table 1) indicating that both patient groups were similar in injury severity and concomitant injuries at hospital admission. During hospital course, patients with good glucose control administration had a significantly decreased incidence of minor infections, sepsis, and MOF, P Ͻ 0.05 (Table 1) . A reduction in infection, and sepsis was associated with improved survival. Although 12% of patients died in the poor glucose group, none of the patients died in the good glucose group, P Ͻ 0.05 (Table 1) . We would like to emphasize that these pathologic events occurred during hospitalization. The Kaplan-Meier-Survival curve is depicted in Figure 1 .
Glucose Metabolism and Insulin Resistance
Daily 6 AM glucose levels were significantly higher in the poor glucose group when compared with good glucose group, P Ͻ 0.05 ( Fig. 2A) . We found that daily 6 AM blood glucose levels were lower in the good glucose control group because of a markedly lower high glucose levels, P Ͻ 0.05 (Fig. 2B) , with no effect on daily low glucose levels (Fig. 2C) .
To determine whether or not decreased glucose levels were the result of increased insulin administration, we determined the 
Annals of Surgery
We found that poor glucose controlled patients required more insulin when compared with the good glucose controlled patients, P Ͻ 0.05 (Fig. 2D) . 
Indirect Calorimetry
As previously reported, burn injury increases REE, indicating a vast hypermetabolic response. In this study, patients with poor glucose control demonstrated a significant increase in REE, as predicted by the Harris-Benedict equation, at various time points when compared with patients with good glucose control, P Ͻ 0.05 (Fig. 3) , indicating that good control was associated with a markedly attenuated hypermetabolic response. 
IFN-
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Cytokines, Hormones, and Proteins
Confirming previous studies, we found that a burn injury induces a vast inflammatory response. Patients with good glucose control demonstrated a marked altered inflammatory response. Good glucose control was associated with significantly decreased IFN-␥, interleukin (IL)-10, IL-7, IL-8, IL-5, IL-6, and monocyte chemoattractant protein (MCP)-1, when compared with patients with poor glucose control, P Ͻ 0.05 (Fig. 4A-G) . Of interest is that IL-6, IL-8, and MCP-1 have been described to induce insulin resistance and that good glucose control attenuated inflammatory mediators that lead to insulin resistance.
Serum acute phase proteins, C-reactive protein, complement C3, ␣ 2 -Macroglobulin, ␣1-antitrypsin, and haptoglobin were increased postburn. Good glucose control had no effect on serum complement C3 and ␣ 2 -macroglobulin, but significantly decreased serum ␣1-Antitrypsin (Fig. 4H), CRP (Fig. 4I) , and haptoglobin (Fig. 4J) . Serum constitutive hepatic proteins prealbumin, transferrin, and retinol-binding protein markedly decreased and remained low up to 60 days postburn. Patients with good glucose control had significantly increased transferrin levels at a later time point when compared with controls, P Ͻ 0.05 (Fig. 4K ).
Organ Function
We further determined serum markers of organ function and homeostasis. We found that burn caused increases in ALT, AST, total bilirubin, BUN, and creatinine levels ( Fig. 4L-T) . Patients with good glucose control had markedly decreased serum ALT (Fig. 4L) , AST (Fig. 4M) , total bilirubin (Fig. 4N) , total protein (Fig. 4O) , BUN (Fig. 4P) , and creatinine (Fig. 4Q ) levels when compared with patients with poor glucose control, P Ͻ 0.05.
DISCUSSION
The introduction of tight euglycemic control as a clinical concept 9, 10 represents one of the milestones in modern medicine and changed ICU practice. 14, 25 However, various recent studies found that tight euglycemic control worsened morbidity and mortality questioning tight euglycemic control as a paradigm. 16, 17 In addition to the essential question whether glucose control per se is beneficial, there is a lot of discussion to which glucose level is associated with beneficial outcome. Van den Berghe et al 9, 10 studies indicate that blood glucose below 110 mg/dL is beneficial in critically ill adults and pediatric patients. However, there are several other studies indicating that 80 to 110 mg/dL does not improve outcomes and is associated with high risk of hypoglycemia. In a recent multicenter trial (VISEP), authors found that insulin administration did not affect mortality but the rate of severe hypoglycemia was 4-fold higher in the intensive therapy group when compared with the conventional therapy group. 16 Finney et al 14 recommend glucose levels of 140 mg/dL and below. Preiser and Devos 15 summarized in their analysis recent studies on glucose modulation. The authors recommend, given the hypoglycemic risks of intensive insulin therapy and the uncertainty of the ideal glucose level, that an intermediate level of 140 mg/dL should be targeted. Following this recommendation is the Surviving Sepsis Campaign. 25 The authors recognized the lack of an ideal glucose range and the complications of hypoglycemic episodes, but they recommend maintaining glucose levels below 150 mg/dL. Because it is very difficult maintaining a continuous hyperinsulinemic, euglycemic clamp in burn patients and the risk of hypoglycemia is increased because the nutrition has to be stopped daily because of dressing changes and operations, the aim of the present study was to determine which glucose range should be targeted to improve morbidity and mortality in this patient population.
We found, using the envelope of a prospective randomized controlled trial in severely burned pediatric patients, that the most beneficial glucose 6 AM target is 130 mg/dL. We used statistical tools to generate a model that determined the ideal glucose levels associated with improved outcomes. We then used this glucose level to stratify the patients and to test whether this model has any validity. The weakness of this study is that it used the same patient population but the strength is that we used approximately 300,000 glucose measurements to determine the ideal glucose level. Furthermore, when we stratified the patients according to the ideal glucose target, we found large differences in terms of outcomes, indicating that our statistical model has validity. By no means are we suggesting that this study replaces a prospective randomized trial determining ideal glucose target, but this is the first scientific effort to come up with a glucose level that is associated with beneficial outcomes. In this trial, we found that morbidity and mortality is improved if a severely thermally injured patient is in that range 75% of the entire acute hospitalization. We furthermore found that a daily average glucose target of 140 mg/dL for 70% of the entire hospitalization is also associated with improved morbidity and mortality. This means that in severely thermally injured patients, glucose levels should be decreased under 140 mg/dL. This finding can be associated with the underlying pathophysiology of hyperglycemia. Several studies suggested that the detrimental effects of hyperglycemia are associated in part with protein glycolysation which occurs at 150 to 160 mg/dL. A glucose target range below 150 mg/dL would avoid protein glycolysation and thus be beneficial in terms of postburn morbidity and mortality.
We would like to mention that daily average glucose values can entail anything from 6 glucose measurements per day up to 24 glucose measurements per day. This depended on injury acuity and the state of critical illness of the patient. Because a different number of measurements of glucose were made in the study patients and more frequent sampling occurred in one group of patients, the results could be biased. We suggest that this is not the case because our 6 AM glucose values are measured once daily in all patients and, is therefore, not bias. We, therefore, propose that our results are valid and skewed.
We have recently shown that a severe burn causes endoplasmic reticulum stress and unfolded protein response in rodents and humans. The endoplasmic reticulum (ER), a membranous organelle that functions in the synthesis and processing of secretory and membrane proteins, is critical in the cellular stress response. 26 Certain pathologic stress conditions disrupt ER homeostasis and lead to accumulation of unfolded or misfolded proteins in the ER lumen. 26 -28 The ER stress response limits unfolded protein burden in the ER lumen by inhibiting translation and inducing the nuclear transcription of additional chaperone proteins. If the unfolding protein burden cannot be reversed, apoptotic cell death ensues. To cope with this stress, cells activate a signal transduction system linking the ER lumen with the cytoplasm and nucleus, called the unfolded protein response. 27, 28 ER stress is detected by transmembrane proteins which monitor the load of unfolded proteins in the ER lumen, and transmit this signal to the cytosol. 26 Two of these proteins, inositol requiring enzyme-1 and PKR-like ER kinase, undergo oligomerization and phosphorylation in response to increased ER stress. 26 Work in our laboratory has recently demonstrated increased phosphorylation of IRE-1 and PERK in rodents and humans after burn injury, indicating activation of ER-stress signaling pathways postburn. We now suggest that ER stress/ unfolded protein response is one of the underlying causes of insulin resistance postburn. What is remarkable in this study is that patients with poor glucose control needed higher insulin doses, which failed to decrease glucose levels, indicating that patients with poor glucose control were more insulin resistant.
This trial was performed in an envelope of a randomized controlled trial but was not a randomized trial. The aim of this trial was to use the dataset from 208 patients and to determine which daily average and 6 AM glucose levels are associated with an improved morbidity and mortality. To determine which glucose target is beneficial, we analyzed approximately 300,000 glucose values and found that burn patients whose 6 AM glucose levels are at 130 mg/dL for 75% of their acute hospitalization has an improved outcome when compared with patients whose glucose levels are above 140 mg/dL. This data is in agreement with several studies recommending a glucose target of 140 to 150 mg/dL. This glucose range does not cause protein glycolysation but, furthermore, is not associated with the risk of severe hypoglycemia. Our data demonstrate that the ideal glucose target is around 130 to 140 mg/dL and that the glucose curve has a U-form shape, meaning that very low glucose levels are as detrimental as very high glucose levels. Given the controversy over glucose range, glucose target, risks and detrimental outcomes associated with hypoglycemia, we thus suggest that in severely burned patients, blood glucose of 130 mg/dL should be targeted. measurements of glucose per patient, a disproportionate sampling of patients in one group could certainly influence or bias the results obtained.
You note that 17 patients, (12%) in the poor control group died, but you do not tell us the causes of death or whether they were related to poor glucose control; for example, fungal infections.
You implicate endoplasmic reticulum stress as a mechanism of poor glucose control in these patients who were in the ICU for 29 to 31 days, but in your recent paper published in Shock, you reported that at 192 hours after injury, the decrease in tyrosine phosphorylation of IRS 1 became subdued and similar activation of that compound, that is, IRS 1, at its tyrosine binding site by insulin administration was observed in both sham and burn groups. If that is the case, will the treatment of glucose disturbance depend on the time after injury and require assays to determine the predominant mechanism at any given time?
DR. LYGIA STEWART (SAN FRANCISCO, CA): You said in your hypothesis the problems were both hypoglycemia and hyperglycemia. Did the patients with hypoglycemia also have increased infections or a worse prognosis?
What was the relationship between the glucose and the percent of body burn? Were the children with a greater percent of body burn more likely to have a higher glucose?
Also, did the location of the burn play a role in the mortality? Were perineal burns more likely to correspond with hyperglycemia? What factor did that play?
DR. JAMES O'NEILL (NASHVILLE, TN):
It is important to remember that this is a study of immature subjects whose metabolisms differ depending on the degree of maturity over time.
Consequently, your patients ranged in age from about 3 years to 14 years. I wonder if you found differences depending on the age and therefore, the level of metabolic maturity, because we do see differences in glucose flow, glucose utilization in different age patients, particularly for those patients under 2 years of age. Is 130 the ideal level for all such patients in this childhood age group? DR. MARC JESCHKE (GALVESTON, TX): Our age range is 0 to 18, but you are absolutely correct. The under 3-year-old patients carry a higher likelihood of death because of cardiac dysfunction and pulmonary edema. There is a difference in hypermetabolic response and inflammatory response. However, in this study, age did not pan out, by the principle component analysis, as the most significant contributor to death. However, you are absolutely right. Age plays an important role in outcome, and we showed this in a paper published in Pediatrics in 2008.
Dr. Stewart, hypoglycemia was detrimental in this principle component analysis and particularly so as hypoglycemia increased. To more specifically answer all these questions, we are currently conducting a prospective randomized trial comparing intensive insulin glycemic control to moderate glycemic control. However, again, in this PCA analysis, we found that hypoglycemia is associated with a worse outcome, as well as hyperglycemia.
And you are absolutely right; patients with bigger burns experience different hypermetabolic and inflammatory responses. However, TBSA adds to this equation, but it is accounted for and therefore, you are right, there is a bigger-burn effect and the cutoff is about 62% where you see an effect on the burn size.
When we focus on glucose levels, it comes down to 130 mg/dL, regardless of the burn size. That is why we prospectively employed this analysis and did not perform a multiple regression analysis.
In regard to Dr. Pruitt's question, this model allows you to compare groups, almost like a propensity score matching, with similar injury severities; similar characteristics when you divide those groups. They experience a poorer outcome simply because of the statistical analysis. At the beginning, these patients are equally stressed, injured, and share similar admission criteria.
However, through the hospital course, some patients are poorly controllable. Some patients are very controllable, and when you look at the insulin data, it is important to initiate good glucose control almost immediately. There appears to be a reason for the increased insulin resistance.
In answer to the question on ER stress, we have shown in our paper published in Shock that the insulin-receptor substrate alteration is tyrosine serum phosphorylation. As we indicated there, we found at 192 hours that it actually evens out.
However, in the mouse study we published in Molecular Medicine last year (2009), we found that ER stress persists. In addition, we conducted a human study, in collaboration with the Glue Grant, host inflammatory response grant, and we found that the genome as well as protein expression ER stress marker were present and persisted for almost up to 1 year postburn, indicating that insulin-resistance persists for about a year.
Thus, there seems to be a two-phase hypermetabolic response. Initially you come down, and then you go back up again. We believe that it is a possible mechanism. All patients received enteral feeding. In these patients, none received TPN. Thus, nutritional intake was based on REE predicted at 1.4 times, as published by Dr. Hart and Dr. Herndon in 2002 in "Critical Care Medicine," and therefore there was no difference.
How many glucose measurements? In our hospital right now, it depends on the acuity. As you can imagine, initially when someone is sick, we measure every 15 minutes or every 30 minutes if needed, then less frequently at the end of the hospital course. You are right, there is an unequal number of glucose measurements, which were somewhat accounted for.
We do continue our feedings through operations. We placed Dobhoff catheters. Thus we do not believe in stopping because of the risk of hypoglycemia. We feed throughout an operation and our anesthesiologists are very lenient and very supportive of this. Therefore, we do not encounter the problem of hypoglycemia when we shut down.
Finally, the cause of death is an excellent question. I am almost convinced that it was because of sepsis the majority of the time. Sepsis, including multi drug resistant organisms, fungi, as well as bacteria play a more important role in our burn unit right now. The majority of the patients died because of sepsis.
